Literature DB >> 33462717

Global Forum of Cancer Surgeons: Support for the Brazilian Society of Surgical Oncology Journey towards Implementation of Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy in Brazil.

Alexandre Ferreira Oliveira1,2, Claudio Almeida Quadros1,2, Héber Salvador de Castro Ribeiro1,2, Alberto Julius Alves Wainstein1, Bruno José de Queiroz Sarmento1, Jorge Lyra1, Glauco Baiocchi Neto1, Reitan Ribeiro1, Rodrigo Nascimento Pinheiro1, Elio José Silveira da Silva Barreto1, Jason Park3, Andrew McKay3, Arnab Gupta4, Dhairyasheel Savant4, Aviram Nissan5, Douglas Zippel5, Augusto Leon6, Juan Enrique Bargallo-Rocha2,7, Hector Martinez Said2,7, Yuko Kitagawa8, Kazuhiro Yoshida8, Woo Yong Lee9, Do Joong Park9, Ashraf Zaghloul10, Wael A Gawad10, Gong Chen11, Haroon Javaid Majid12, Muhammad Arshad Cheema12, Alessandro Gronchi13, Tibor Kovacs14, Domenico D'Ugo13,14, David L Bartlett15, James R Howe15, Chandrakanth Are16.   

Abstract

Entities:  

Year:  2021        PMID： 33462717     DOI： 10.1245/s10434-020-09527-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

Review 1.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis.

Authors:  Joseph H Helm; John T Miura; Jason A Glenn; Rebecca K Marcus; Gregory Larrieux; Thejus T Jayakrishnan; Amy E Donahue; T Clark Gamblin; Kiran K Turaga; Fabian M Johnston
Journal:  Ann Surg Oncol       Date:  2014-08-15       Impact factor: 5.344

2.  Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series.

Authors:  Paul H Sugarbaker; O Anthony Stuart
Journal:  Surg Oncol       Date:  2020-01-25       Impact factor: 3.279

3.  Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Dario Baratti; Shigeki Kusamura; Antonello Domenico Cabras; Rossella Bertulli; Ionut Hutanu; Marcello Deraco
Journal:  Eur J Cancer       Date:  2013-07-04       Impact factor: 9.162

Review 4.  Update on the management of malignant peritoneal mesothelioma.

Authors:  Paul H Sugarbaker
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 5.  Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.

Authors:  P H Sugarbaker; D Chang
Journal:  Eur J Surg Oncol       Date:  2017-01-29       Impact factor: 4.424
  5 in total
  2 in total

1.  The State of the SSO: Responding to the Pandemic and Beyond.

Authors:  James R Howe
Journal:  Ann Surg Oncol       Date:  2021-04-23       Impact factor: 5.344

2.  Global Forum of Cancer Surgeons: Cancer Surgery During the COVID-19 Pandemic: Impact and Lessons Learned.

Authors:  Chandrakanth Are; D Tyler; J Howe; A Olivares; A Nissan; D Zippel; A Gupta; D Savant; D D'Ugo; I Rubio; J E Bargallo-Rocha; H Martinez-Said; H Takeuchi; A Taketomi; A F Oliveira; H S Castro Ribeiro; M A Cheema; H J Majid; G Chen; F Roviello; A Gronchi; A Leon; W Y Lee; D J Park; J Park; R Auer; W A Gawad; A Zaghloul
Journal:  Ann Surg Oncol       Date:  2022-02-24       Impact factor: 4.339
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.